nefiracetam has been researched along with Neuroblastoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fujita, R; Koji, T; Ueda, H; Ueda, M | 1 |
| Murashima, YL; Nukada, T; Shiotani, T; Watabe, S; Yoshii, M | 1 |
2 other study(ies) available for nefiracetam and Neuroblastoma
| Article | Year |
|---|---|
The cognition-enhancer nefiracetam inhibits both necrosis and apoptosis in retinal ischemic models in vitro and in vivo.
Topics: Animals; Apoptosis; Brain-Derived Neurotrophic Factor; Cognition; Eye Diseases; Hybridomas; Ischemia; Mice; Necrosis; Neuroblastoma; Neuroprotective Agents; Pyrrolidinones; Rats; Reperfusion Injury; Retina; Tumor Cells, Cultured | 2004 |
Cellular mechanism of action of cognitive enhancers: effects of nefiracetam on neuronal Ca2+ channels.
Topics: Animals; Calcium Channels, L-Type; Calcium Channels, N-Type; Cognition; Cyclic AMP; Glioma; GTP-Binding Proteins; Humans; Neuroblastoma; Neurons; Nootropic Agents; Oocytes; Pyrrolidinones; Signal Transduction; Tumor Cells, Cultured; Xenopus | 2000 |